IP Verse

Allergan competitive analysis

Loading summary...

Latest oppositions filed by Allergan

Explore patent oppositions filed by Allergan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3236939
Botulinum Toxin Prefilled ContainerMERZ PHARMADec 31, 2020
EP3233043
Process For Preparing HydrogelsTEOXANEAug 5, 2020
EP3274685
Process For Evaluating The Mechanical Performance Of A Filler GelTEOXANEJul 2, 2020
EP3027186
Composition Comprising Hyaluronic Acid And MepivacaineTEOXANEMar 18, 2020
EP2912074
Dermal Injectable Sterile CompositionTEOXANEFeb 3, 2020
EP2939688
Pharmaceutical Compositions Comprising Botulinum NeurotoxinIPSEN BIOPHARMNov 20, 2019
EP3250185
Ophthalmic Suspension CompositionBAUSCH & LOMB INCORPORATEDSep 4, 2019
EP2627318
Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian ExcipientsMERZ PHARMAMay 16, 2018
EP2661276
Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin CompositionsREVANCE THERAPEUTICSMay 2, 2018
EP2800811
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERFeb 11, 2018

Latest patents of Allergan opposed by its competitors

Explore Allergan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3681500
Jul 30, 2025Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions1
EP2442821
Feb 12, 2025Safe Desmopressin Administration1
EP3351237
Dec 18, 2024Hyaluronic Acid-Collagen Matrices For Dermal Filling And Volumizing Applications1
EP3509559
Jul 19, 2023Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof1
EP2877138
Jun 28, 2023Dual Cap System For Container-Closures To Maintain Tip Sterility During Shelf Storage1
EP2381923
Jun 7, 2023Safe Desmopressin Administration1
EP3024479
Feb 8, 2023High Potency Pancreatin Pharmaceutical Compositions1
EP3436054
Jul 27, 2022Stabilized Non-Protein Clostridial Toxin Compositions1
EP3520827
May 25, 2022Cross-Linked Hydrogels For Soft Tissue Augmentation1
EP3431074
Jan 19, 2022Preservative Free Bimatoprost And Timolol Solutions6

Latest publications and patents of Allergan New

Explore the latest publications and patents granted to Allergan, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Allergan

EP3681500
Jul 30, 2025Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular ConditionsPatent Maintained As Amended
EP2442821
Feb 12, 2025Safe Desmopressin AdministrationPatent Maintained As Amended
EP3351237
Dec 18, 2024Hyaluronic Acid-Collagen Matrices For Dermal Filling And Volumizing ApplicationsGranted And Under Opposition
EP3509559
Jul 19, 2023Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing ThereofGranted And Under Opposition
EP2877138
Jun 28, 2023Dual Cap System For Container-Closures To Maintain Tip Sterility During Shelf StorageGranted And Under Opposition
EP2381923
Jun 7, 2023Safe Desmopressin AdministrationPatent Maintained As Amended
EP3024479
Feb 8, 2023High Potency Pancreatin Pharmaceutical CompositionsPatent Maintained As Amended
EP3436054
Jul 27, 2022Stabilized Non-Protein Clostridial Toxin CompositionsPatent Maintained As Amended
EP3520827
May 25, 2022Cross-Linked Hydrogels For Soft Tissue AugmentationRevoked
EP3431074
Jan 19, 2022Preservative Free Bimatoprost And Timolol SolutionsGranted And Under Opposition

Latest PTAB cases involving Allergan

Discover the latest PTAB cases involving Allergan, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 27, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Allergan

IPR2021-00296Dec 14, 2020ALLERGANBTL MEDICAL SROTerminated-Settled
IPR2021-00312Dec 14, 2020ALLERGANBTL MEDICAL SROTerminated-Settled
PGR2021-00015Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00016Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00017Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00018Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00020Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00021Dec 14, 2020ALLERGANBTL MEDICAL SROInstitution Denied
PGR2021-00022Dec 14, 2020ALLERGANBTL MEDICAL SROTerminated-Settled
PGR2021-00023Dec 14, 2020ALLERGANBTL MEDICAL SROTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Allergan with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALLERGAN INDUSTRIE - 11 - 10
LABORATOIRES VIVACY11 - - -
MERZ PHARMA176 - -
PROLLENIUM - - 9 -